Stockreport

Generics Player ANI Pharmaceuticals Strengthens Rare Disease Segment With $380M Alimera Sciences Deal [Yahoo! Finance]

ANI Pharmaceuticals, Inc.  (ANIP) 
Last ani pharmaceuticals, inc. earnings: 2/27 08:30 am Check Earnings Report
PDF non-tradable contingent value right (CVR) of up to $0.50 per share upon the achievement of certain net revenue targets in 2026 and 2027 ANI will also repay $72.5 milli [Read more]